
Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India

Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio



